Inovio Pharmaceuticals Inc. (INO)

Trade INO now with
3/14/2018 4:09:00 PM Inovio Pharmaceuticals Q4 Loss/shar $0.24 Vs. Loss $0.35 Year Ago
1/9/2018 8:05:19 AM Inovio And Parker Institute For Cancer Immunotherapy Collaborate To Evaluate Novel Cancer Immunotherapy Combinations
1/8/2018 8:07:59 AM Inovio Receives Milestone Payment From MedImmune
1/2/2018 8:03:13 AM Inovio Enters License, Collaboration Agreement With ApolloBio To Develop VGX-3100 In China
12/6/2017 8:02:03 AM Inovio Pharmaceuticals Adds Wendy Yarno To Board
11/29/2017 8:04:33 AM Inovio’s Analysis Of VGX-3100 Phase 2b Data Reveals Immune Correlates And Biomarker Signatures That Predicted Efficacy
11/8/2017 4:08:54 PM Inovio Pharma Q3 Loss Per Share $0.40 Vs Loss $0.28 Last Year
11/1/2017 9:21:52 AM Inovio Initiates Phase 1b/2a Immuno-oncology Trial In Patients With Newly Diagnosed Glioblastoma
10/16/2017 7:02:23 AM Inovio Pharma Begins Phase 1b/2 Cancer Efficacy Trial To Evaluate Roche’s Atezolizumab In Combination With INO-5401
10/5/2017 7:02:56 AM Inovio’s Positive Zika Vaccine Clinical Study Data Published In New England Journal Of Medicine
9/18/2017 8:02:40 AM Inovio And Partners Initiate Phase 1/2a Trial To Further Advance Vaccine Against Deadly MERS Infection